v3.26.1
Consolidated statements of income - EUR (€)
€ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Healthcare services € 3,252,174 € 3,225,352 € 6,396,681 € 6,501,665
Healthcare products 1,090,020 1,078,082 2,110,641 2,179,863
Insurance contracts 518,372 488,279 965,391 991,639
Revenue 4,860,566 4,791,713 9,472,713 9,673,167
Costs of revenue:        
Healthcare services 2,497,489 2,521,355 4,971,457 5,164,454
Healthcare products 571,890 585,135 1,095,061 1,157,122
Insurance contracts 481,205 470,862 916,721 953,252
Costs of revenue 3,550,584 3,577,352 6,983,239 7,274,828
Operating (income) expenses:        
Selling, general and administrative 736,012 791,979 1,484,950 1,542,665
Research and development 39,630 38,116 77,939 81,598
(Income) loss from equity method investees 41,256 (45,175) (66) (93,008)
Other operating income (207,606) (342,945) (365,991) (484,260)
Other operating expense 234,835 347,103 540,592 594,671
Operating income 465,855 425,283 752,050 756,673
Other (income) expense:        
Interest income (14,698) (21,852) (29,319) (36,830)
Interest expense 97,554 96,581 190,854 192,296
Income before income taxes 382,999 350,554 590,515 601,207
Income tax expense 89,829 78,259 132,582 139,303
Net income 293,170 272,295 457,933 461,904
Net income attributable to noncontrolling interests 74,793 47,025 122,027 85,412
Net income attributable to shareholders of FME AG € 218,377 € 225,270 € 335,906 € 376,492
Basic earnings per share € 0.81 € 0.77 € 1.24 € 1.28
Diluted earnings per share € 0.81 € 0.77 € 1.24 € 1.28